Circadian rhythms: a possible new player in non-alcoholic fatty liver disease pathophysiology

被引:0
|
作者
Davide Gnocchi
Carlo Custodero
Carlo Sabbà
Antonio Mazzocca
机构
[1] University of Bari School of Medicine,Interdisciplinary Department of Medicine
来源
关键词
Non-alcoholic fatty liver disease (NAFLD); Non-alcoholic steatohepatitis (NASH); Hepatocellular carcinoma (HCC); Circadian rhythms; Metabolism; Metabolic syndrome; Insulin resistance;
D O I
暂无
中图分类号
学科分类号
摘要
Over the last decades, a better knowledge of the molecular machinery supervising the regulation of circadian clocks has been achieved, and numerous findings have helped in unravelling the outstanding significance of the molecular clock for the proper regulation of our physiologic and metabolic homeostasis. Non-alcoholic fatty liver disease (NAFLD) is currently considered as one of the emerging liver pathologies in the Western countries due to the modification of eating habits and lifestyle. Although NAFLD is considered a pretty benign condition, it can progress towards non-alcoholic steatohepatitis (NASH) and eventually hepatocellular carcinoma (HCC). The pathogenic mechanisms involved in NAFLD development are complex, since this disease is a multifactorial condition. Major metabolic deregulations along with a genetic background are believed to take part in this process. In this light, the aim of this review is to give a comprehensive description of how our circadian machinery is regulated and to describe to what extent our internal clock is involved in the regulation of hormonal and metabolic homeostasis, and by extension in the development and progression of NAFLD/NASH and eventually in the onset of HCC.
引用
收藏
页码:741 / 759
页数:18
相关论文
共 50 条
  • [41] Maternal Obesity Promotes Offspring Non-Alcoholic Fatty Liver Disease (NAFLD) through Disruption of Molecular Circadian Rhythms
    Mouralidarane, Angelina
    Soeda, Junpei
    Carter, Rebeca
    Pombo, Joaquim
    Sugden, David
    Seed, Paul T.
    Taylor, Paul D.
    Poston, Lucilla
    Oben, Jude A.
    HEPATOLOGY, 2012, 56 : 318A - 318A
  • [42] Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Eslami, Layli
    Merat, Shahin
    Malekzadeh, Reza
    Nasseri-Moghaddam, Siavosh
    Aramin, Hermineh
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (12):
  • [43] Non-alcoholic fatty liver disease as a consequence of autonomic imbalance and circadian desynchronization
    Sabath, E.
    Baez-Ruiz, A.
    Buijs, R. M.
    OBESITY REVIEWS, 2015, 16 (10) : 871 - 882
  • [44] Non-alcoholic fatty liver disease: the role of nuclear receptors and circadian rhythmicity
    Mazzoccoli, Gianluigi
    Vinciguerra, Manlio
    Oben, Jude
    Tarquini, Roberto
    De Cosmo, Salvatore
    LIVER INTERNATIONAL, 2014, 34 (08) : 1133 - 1152
  • [45] Non-Alcoholic Fatty Pancreas Disease Pathogenesis: A Role for Developmental Programming and Altered Circadian Rhythms
    Carter, Rebeca
    Mouralidarane, Angelina
    Soeda, Junpei
    Ray, Shuvra
    Pombo, Joaquim
    Saraswati, Ruma
    Novelli, Marco
    Fusai, Giuseppe
    Rappa, Francesca
    Saracino, Chiara
    Pazienza, Valerio
    Poston, Lucilla
    Taylor, Paul D.
    Vinciguerra, Manlio
    Oben, Jude A.
    PLOS ONE, 2014, 9 (03):
  • [46] Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation
    Burke, A
    Lucey, MR
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (05) : 686 - 693
  • [47] Statins for non-alcoholic fatty liver disease: a new indication?
    Liberopoulos, E. N.
    Athyros, V. G.
    Elisaf, M. S.
    Mikhailidis, D. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (04) : 698 - 699
  • [48] Ghrelin: a new treatment for non-alcoholic fatty liver disease?
    Patric J. D. Delhanty
    Aart J. van der Lely
    Endocrine, 2013, 43 : 247 - 248
  • [49] What's new in non-alcoholic fatty liver disease?
    Spiers, Jessica
    Brindley, James Hallimond
    Li, Wenhao
    Alazawi, William
    FRONTLINE GASTROENTEROLOGY, 2022, 13 (E1) : E102 - E108
  • [50] Non-alcoholic fatty liver disease - What's new
    Roeb, Elke
    Steffen, Hans-Michael
    Bojunga, Joerg
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2016, 141 (07) : 494 - 496